October 30, 2018
Rose
Fallout from questions raised about the research and journal publications from the lab of Dr. Piero Anversa, a controversial stem cell researcher, leads a federal agency to temporarily halt a clinical trial studying a stem cell therapy for heart failure patients. And The New York Times reports more on Anversa's troubles.
from Kaiser Health News https://ift.tt/2AzYjTz
October 30, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Health Care Gets Heated On Night 2 Of The Democratic Presidential Debate- Louisiana Forges Ahead With Novel Plan To Use Subscription Netflix-Like System To Bring Down Drug Costs
- Trump Has Blessed States’ Exploration Of Importing Drugs. Will It Catch On?
- Pelosi Aims For Feds To Negotiate Drug Prices, Even For Private Insurers
- A Million Californians Don’t Have Clean Drinking Water. Where Do They Live?
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment